Literature DB >> 6095751

Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells.

Y C Cheng, S P Grill, G E Dutschman, K B Frank, J F Chiou, K F Bastow, K Nakayama.   

Abstract

We examined the effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) on viral DNA, RNA, protein, and enzyme synthesis in HeLa cells infected with herpes simplex virus type 1 and type 2. DHPG inhibited virus DNA synthesis in a dose-dependent fashion. This inhibition was not due to the lack of deoxynucleoside triphosphates which are required for DNA synthesis. This compound has no apparent effect on early and late viral RNA synthesis, viral protein synthesis, or viral thymidine kinase, DNA polymerase, and DNase induction in virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095751      PMCID: PMC176152          DOI: 10.1128/AAC.26.3.283

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.

Authors:  L S Lee; Y C Cheng
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

2.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

3.  Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus.

Authors:  L W Enquist; G F Vande Woude; M Wagner; J R Smiley; W C Summers
Journal:  Gene       Date:  1979-11       Impact factor: 3.688

4.  The deoxyribonuclease induced after infection of KB cells by herpes simplex virus type 1 or type 2. I. Purification and characterization of the enzyme.

Authors:  P J Hoffmann; Y C Cheng
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

5.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

8.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses.

Authors:  W C Russell; C Newman; D H Williamson
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

9.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

10.  Properties of herpes simplex virus type 1 and type 2 DNA polymerase.

Authors:  M Ostrander; Y C Cheng
Journal:  Biochim Biophys Acta       Date:  1980-09-19
View more
  8 in total

1.  Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine.

Authors:  M N Prichard; L E Prichard; W A Baguley; M R Nassiri; C Shipman
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

2.  Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.

Authors:  A H Karlsson; J G Harmenberg; B E Wahren
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Authors:  V R Freitas; D F Smee; M Chernow; R Boehme; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

4.  Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.

Authors:  A C Scheck; B Wigdahl; E De Clercq; F Rapp
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.

Authors:  A Karlsson; J Harmenberg
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 6.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

7.  Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats.

Authors:  Sriram Gunda; Ravinder Earla; Kishore Cholkar; Ashim K Mitra
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-19       Impact factor: 2.441

8.  A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.

Authors:  M N Prichard; N Gao; S Jairath; G Mulamba; P Krosky; D M Coen; B O Parker; G S Pari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.